Sign in

CIK 0000887359

  • Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
Operating
EIN
943096597
Phone
+1 617-588-5555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,896,581
in 8 filings, $5.8M under 10b5-1 plans

Net −$5,896,581. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 ZERBE ROBERT L MD Director Exercise or conversion 10b5-1 +2,000 $13.05 $26K 34,995
2026-11-09 ZERBE ROBERT L MD Director Sale 10b5-1 −2,000 $57.88 $116K 32,995
2026-11-09 ZERBE ROBERT L MD Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 +2,000 0
2026-11-05 ZERBE ROBERT L MD Director Exercise or conversion 10b5-1 +500 $13.05 $7K 33,495
2026-11-05 ZERBE ROBERT L MD Director Sale 10b5-1 −500 $55.00 $28K 32,995
2026-11-05 ZERBE ROBERT L MD Director Exercise or conversion 10b5-1 +2,500 $13.05 $33K 35,495
2026-11-05 ZERBE ROBERT L MD Director Sale 10b5-1 −2,500 $51.67 $129K 32,995
2026-11-05 ZERBE ROBERT L MD Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 +500 4,500
2026-11-05 ZERBE ROBERT L MD Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 +2,500 2,000
2026-11-04 ZERBE ROBERT L MD Director Exercise or conversion 10b5-1 +2,500 $13.05 $33K 35,495
2026-11-04 ZERBE ROBERT L MD Director Sale 10b5-1 −2,500 $45.40 $114K 32,995
2026-11-04 ZERBE ROBERT L MD Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 +2,500 5,000
2026-04-29 ZERBE ROBERT L MD Director Exercise or conversion +3,200 32,995
2026-04-29 ZERBE ROBERT L MD Director Exercise or conversion · Restricted Stock Unit +3,200 0
2026-04-29 ZERBE ROBERT L MD Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2026-04-29 ZERBE ROBERT L MD Director Grant or award · Restricted Stock Unit +3,200 3,200
2025-04-30 ZERBE ROBERT L MD Director Exercise or conversion +3,200 29,795
2025-04-30 ZERBE ROBERT L MD Director Exercise or conversion · Restricted Stock Unit +3,200 0
2025-04-30 ZERBE ROBERT L MD Director Grant or award · Stock Option (Right to Buy) +8,000 8,000
2025-04-30 ZERBE ROBERT L MD Director Grant or award · Restricted Stock Unit +3,200 3,200

Page 1 of 5 · 100 trades